EVolution Therapeutics is thrilled to announce its selection to join the first cohort of SPARK The Midlands, the inaugural UK branch of the globally recognised...
CEO of EVolution therapeutics, Dr James Gavin, was invited to present at the first-ever Midlands EV Network event. Here he shared his experience of co-founding...
EVolution Therapeutics has achieved another milestone by securing additional grant funding of £238,000, to work in collaboration with world leading biomaterials...
We are delighted to announce that EVolution Therapeutics has secured a £284,000 Innovate UK grant to develop an advanced wound care therapeutic for the treatment...
EVs are novel candidates for the delivery of bio-active molecules with their high bioavailability, intrinsic capability to cross biological barriers and remarkable...